Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.

by Benjamin Mou, Chris J Beltran, Sean S Park, Kenneth R Olivier, Keith M Furutani
Published 2014-01-01

Technical Delivery Parameters of 2000 Proton Treatment Courses

by Amanda J. Deisher, Thomas J. Whitaker, Chris J. Beltran, Robert L. Foote, Michael G. Haddock, Anita Mahajan
Published 2020-02-01

Knowledge of endoscopic ultrasound-delivered fiducial composition and dimension necessary when planning proton beam radiotherapy

by Ferga C. Gleeson, Erik J. Tryggestad, Nicholas B. Remmes, Chris J. Beltran, Jon J. Kruse, Michael G. Haddock, Christopher L. Hallemeier, Andrew C. Storm, Michael J. Levy
Published 2018-06-01

A High-Precision Method for In Vitro Proton Irradiation

by Michelle E. Howard, PhD, Janet M. Denbeigh, Emily K. Debrot, PhD, Nicholas B. Remmes, PhD, Michael G. Herman, PhD, Chris J. Beltran, PhD
Published 2020-10-01

The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers

by Jaden D. Evans, MD, Riley H. Harper, BS, Molly Petersen, MS, William S. Harmsen, MS, Aman Anand, PhD, Ashley Hunzeker, CMD, Noelle C. Deiter, RTT, Heather Schultz, CMD, Krishan R. Jethwa, MD, Scott C. Lester, MD, David M. Routman, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben-Wittich, MD, Nadia N. Laack, MD, Chris J. Beltran, PhD, Samir H. Patel, MD, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Daniel W. Mundy, PhD, Robert L. Foote, MD
Published 2020-08-01